T14504 |
BAY 38-7271
|
212188-60-8
|
98%
|
|
BAY 38-7271 has strong neuroprotective properties.[1] BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist. With Kis of 1.85 nM an...
|
T17027 |
Tedalinab
|
916591-01-0
|
98%
|
|
Tedalinab is an effective and selective cannabinoid receptor 2 agonist. Tedalinab has the potential for neuropathic pain and osteoarthritis treatment. Tedalinab ...
|
T10510 |
CB1 antagonist 1
|
890037-68-0
|
98%
|
|
CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and gast...
|
T13081 |
Taranabant racemate
|
701977-00-6
|
98%
|
|
Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor.
|
T64394 |
GW 833972A
|
1092502-33-4
|
98%
|
|
GW 833972A is a selective CB2 receptor agonist.GW 833972A has an inhibitory effect on induced neural depolarization and on citric acid-induced cough in an animal...
|
T29930 |
AM-1235
|
335161-27-8
|
98%
|
|
AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.
|
T19705 |
JTE-907
|
282089-49-0
|
98%
|
|
|
T67896 |
CB2R/FAAH modulator-1
|
928892-60-8
|
98%
|
|
CB2R/FAAH modulator-1, a cannabinoid type 2 receptor (CB2R) agonist, is also a fatty acid amide hydrolase (FAAH) inhibitor (IC50=4 μM) that reduces the productio...
|
T8511 |
TM38837
|
1253641-65-4
|
98%
|
|
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.
|
T24771 |
SCH-336
|
447459-51-0
|
98%
|
|
SCH-336 is a CB2 receptor agonist (Ki-1.8 nM, EC50-2 nM) with effective, selective, and oral activity. SCH-336 is also bioactive against CB1 receptor, and is 100...
|
TN5131 |
Tetrahydrocannabivarin
|
31262-37-0
|
98%
|
|
Tetrahydrocannabivarin is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, th...
|
TN3575 |
(±)-Cannabichromene
|
20675-51-8
|
98%
|
|
Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 ...
|
T14302 |
Olorinab
|
1268881-20-4
|
98%
|
|
Olorinab (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2.
|
T9114 |
β-Caryophyllene
|
87-44-5
|
98%
|
|
β-Caryophyllene acts as an CB2 receptor agonist.
|
T1915 |
AM251
|
183232-66-8
|
98%
|
|
AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-fold selectivity over CB2 receptors; also effective GPR55 agonist (EC50: 39 ...
|
T7375 |
A-836339
|
959746-77-1
|
98%
|
|
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 recep...
|
T2635 |
Org 27569
|
868273-06-7
|
98%
|
|
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and e...
|
T22009 |
CB2 receptor agonist 2
|
1314230-75-5
|
98%
|
|
CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and sel...
|
T37075 |
CB2R PAM
|
2244579-87-9
|
98%
|
|
CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive mutational modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]G...
|
T28468 |
PSNCBAM-1
|
877202-74-9
|
98%
|
|
PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.
|